H.R.1285: To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

About this Bill

This bill was introduced in the 113th Congress
This bill is primarily about crime and law enforcement
You can read the bill
Sponsor Vern Buchanan, R-Fla.
Total Cosponsors 54 (23 Democrats, 32 Republicans)
Introduced March 20, 2013
Latest Major Action April 15, 2013
See it on GovTrack
See it on C-SPAN

Bill Progress

  • Bill introduced in the House   
  • Bill passed in the House   
  • Bill passed in the Senate   
  • Bill signed into law

Bill Summary

Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

(Source: Congressional Research Service)

Bill Actions

Date Description
April 15, 2013 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.
March 22, 2013 Referred to the Subcommittee on Health.
March 20, 2013 Referred to House Judiciary
March 20, 2013 Referred to House Energy and Commerce